Clinical Trial Update: Improving Quality of Life of Prostate Cancer Survivors With Androgen Deficiency [Phase 2]

View source ↗

Summary

Phase 2 clinical trial assessing interventions to improve quality of life in prostate cancer survivors with androgen deficiency; the study has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Prostate Cancer

Snippet

Sponsor: Dana-Farber Cancer Institute | Conditions: Prostate Cancer | Phase 2 | Status: COMPLETED